Gang Kuang

1.4k total citations
49 papers, 1.1k citations indexed

About

Gang Kuang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gang Kuang has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Gang Kuang's work include Cancer-related gene regulation (18 papers), Epigenetics and DNA Methylation (14 papers) and RNA modifications and cancer (10 papers). Gang Kuang is often cited by papers focused on Cancer-related gene regulation (18 papers), Epigenetics and DNA Methylation (14 papers) and RNA modifications and cancer (10 papers). Gang Kuang collaborates with scholars based in China and Germany. Gang Kuang's co-authors include Wei Guo, Yanli Guo, Zhiming Dong, Supeng Shen, Zhibin Yang, Zhiming Dong, Denggui Wen, Zhifeng Chen, Jia Liang and Xin Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Hepatology.

In The Last Decade

Gang Kuang

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang Kuang China 21 741 395 194 163 89 49 1.1k
Zein Mersini Besharat Italy 21 730 1.0× 291 0.7× 232 1.2× 77 0.5× 60 0.7× 51 1.2k
Yajing Zhang China 20 756 1.0× 408 1.0× 142 0.7× 76 0.5× 90 1.0× 56 1.1k
Kun Wu China 19 838 1.1× 515 1.3× 249 1.3× 186 1.1× 121 1.4× 59 1.3k
Pei‐Li Yao United States 19 657 0.9× 219 0.6× 378 1.9× 76 0.5× 94 1.1× 32 1.4k
H. Lee Taiwan 17 530 0.7× 235 0.6× 250 1.3× 49 0.3× 92 1.0× 21 891
Beatrice Faraglia Italy 18 601 0.8× 230 0.6× 405 2.1× 201 1.2× 151 1.7× 22 1.1k
Umar Wazir United Kingdom 19 319 0.4× 330 0.8× 199 1.0× 208 1.3× 94 1.1× 63 885

Countries citing papers authored by Gang Kuang

Since Specialization
Citations

This map shows the geographic impact of Gang Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Kuang more than expected).

Fields of papers citing papers by Gang Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Kuang. The network helps show where Gang Kuang may publish in the future.

Co-authorship network of co-authors of Gang Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Kuang. A scholar is included among the top collaborators of Gang Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Kuang. Gang Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yu, Qinwei, et al.. (2025). Luteolin modulates liver macrophage subtype polarization and play protective role in sepsis induced acute hepatic injury. Inflammation Research. 74(1). 59–59. 5 indexed citations
3.
Xu, Minxuan, Junjie Zhao, Liancai Zhu, et al.. (2024). Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression. Journal of Hepatology. 82(2). 277–300. 4 indexed citations
5.
Chen, Yongchun, et al.. (2023). In Vitro Investigation of the Anticancer Activity of Peucedanum praeruptorum Dunn Extract on HepG2 Human Hepatoma Cells. Journal of Food Quality. 2023. 1–10. 1 indexed citations
6.
Luo, Jing, Jun Tan, Junjie Zhao, et al.. (2022). Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis. International Immunopharmacology. 113(Pt B). 109395–109395. 4 indexed citations
7.
Lou, Deshuai, Xiaoli Zhang, Zixin Zhou, et al.. (2022). A novel NADP(H)-dependent 3α-HSDH from the intestinal microbiome of Ursus thibetanus. International Journal of Biological Macromolecules. 219. 159–165. 2 indexed citations
8.
Guo, Wei, Ping Lv, Shengnan Liu, et al.. (2018). Aberrant methylation‐mediated downregulation of long noncoding RNA C5orf66‐AS1 promotes the development of gastric cardia adenocarcinoma. Molecular Carcinogenesis. 57(7). 854–865. 25 indexed citations
9.
Guo, Wei, Zhiming Dong, Shengnan Liu, et al.. (2017). Promoter hypermethylation‐mediated downregulation of miR‐770 and its host gene MEG3, a long non‐coding RNA, in the development of gastric cardia adenocarcinoma. Molecular Carcinogenesis. 56(8). 1924–1934. 50 indexed citations
10.
Guo, Wei, Cong Wang, Yanli Guo, et al.. (2015). RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 32(1). 83–98. 22 indexed citations
11.
Guo, Wei, Tienian Zhu, Zhiming Dong, et al.. (2013). Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 30(8). 977–992. 23 indexed citations
12.
Zhang, Shun, Gang Kuang, Guodong Zhao, et al.. (2013). Involvement of the mitochondrial p53 pathway in PBDE-47-induced SH-SY5Y cells apoptosis and its underlying activation mechanism. Food and Chemical Toxicology. 62. 699–706. 56 indexed citations
13.
Guo, Wei, et al.. (2012). Genetic and epigenetic alterations of WWOX in the development of gastric cardia adenocarcinoma. Environmental and Molecular Mutagenesis. 54(2). 112–123. 15 indexed citations
14.
Dong, Zhiming, Wei Guo, Yanli Guo, Gang Kuang, & Zhibin Yang. (2012). Concordant Promoter Methylation of Transforming Growth Factor-Beta Receptor Types I and II Occurs Early in Esophageal Squamous Cell Carcinoma. The American Journal of the Medical Sciences. 343(5). 375–381. 15 indexed citations
15.
Guo, Wei, Zhiming Dong, Yanli Guo, et al.. (2011). Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma. Molecular Biology Reports. 39(4). 4301–4309. 12 indexed citations
16.
Guo, Wei, et al.. (2011). Decreased expression of WWOX in the development of esophageal squamous cell carcinoma. Molecular Carcinogenesis. 52(4). 265–274. 21 indexed citations
17.
Guo, Wei, Zhiming Dong, Zhifeng Chen, et al.. (2009). Aberrant CpG Island Hypermethylation of RASSF1A in Gastric Cardia Adenocarcinoma. Cancer Investigation. 27(4). 459–465. 36 indexed citations
18.
Dong, Zhiming, Wei Guo, Rong‐Miao Zhou, et al.. (2008). Polymorphisms of the DNA Repair Gene XPA and XPC and its Correlation With Gastric Cardiac Adenocarcinoma in a High Incidence Population in North China. Journal of Clinical Gastroenterology. 42(8). 910–915. 36 indexed citations
19.
Chen, Hu, et al.. (2007). [Diethylstilbestrol intervention in carcinogenesis of breast cancer in wistar rats].. PubMed. 26(6). 596–600. 1 indexed citations
20.
Zhang, Jianhui, Yan Li, Rui Wang, et al.. (2003). Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. International Journal of Cancer. 105(2). 281–284. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026